Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Will Turkey Ever Regulate Its OTC Market?

Executive Summary

Turkey’s Ministry of Health has announced work on extending the list of non-prescription medicines to reduce the financial burden on the country's Social Security Institution. However, Turkey first needs to take other steps to open up its marketplace for non-prescription drugs.

You may also be interested in...



Turkey Poised To Stretch Consumer Health Market; Rigid On Ads, Access

Some 80 pharmaceutical and vitamin products already are available nonprescription in parts of Turkey, but a proposal in development for almost two years would be the country's first regulation for sales of consumer health care products.

Turkey Poised To Stretch Consumer Health Market; Rigid On Ads, Access

Some 80 pharmaceutical and vitamin products already are available nonprescription in parts of Turkey, but a proposal in development for almost two years would be the country's first regulation for sales of consumer health care products.

Medtech Procurement A Victim Of Turkey’s Ongoing Economic Troubles

The devaluation of the Turkish Lira since May is making imports of medical devices more expensive and putting hospital procurement under renewed pressure. The local medtech industry associations TUMDEF and ARTED describe the problems  ̶  and the solutions  ̶  to Medtech Insight.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS118933

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel